PLoS ONEBioinformaticsPeer-reviewed journal article
In silico exploration of potent flavonoids for dengue therapeutics
Anuraj PhunyaliD, Jhashanath Adhikari SubiniD, Achyut AdhikariiD
Abstract
Dengue poses a persistent and widespread threat with no effective antiviral drug available till now. Several inhibitors have been developed by targeting the viral non-structural proteins including methyl transferase (NS5) of the dengue virus with possible therapeutic values. In this work, virtual screening, molecular docking, molecular dynamics simulations (200 ns), and assessments of free energy changes to identify potential candidates from a database of flavonoids (ca. 2000) that may have good curative potential from the disease. The binding affinity of flavonoids, namely Genistein-7-glucoside (FLD1), 6-O-Acetylgenistin (FLD2), 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxane-2-yl]oxychromen-4-one (FLD3), Glucoliquiritigenin (FLD4), and Chrysin-7-O-glucoronide (FLD5) showed the binding affinities of -10.2, -10.2, -10.1, -10.1, -9.9 kcal/mol, respectively, and possessed better values than that of the native ligand with showed (-7.6 kcal/mol) and diclofenac sodium (-7.3 kcal/mol). Drug-likeness of these compounds was acceptable and no toxicity was hinted by ADMET predictions. The stability of the protein-ligand complexes was accessed from 200 ns molecular dynamics simulation in terms of various geometrical parameters; RMSD, RMSF of residues, Rg, SASA, and H-bond of the protein-ligand complexes. The binding free energy changes of these compounds were calculated by the MM-PBSA solvation model with negative values (less than -38.01{+/-}7.53 kcal/mol) indicating the spontaneity of the forward reaction and favorability of the product formation. The geometrical and thermodynamic parameters infer that the flavonoid binds at the orthosteric site of the target protein of DENV-2 and could inhibit its functioning resulting in the prevention of the disease. Overall, this study highlights the anti-DENV activity of five flavonoids, positioning them as promising candidates for further development as antiviral agents against dengue infection.
- Citations
- 13
- FWCI
- 2.75
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Experimental and computational studies on molecular mechanism by which Curcumin allosterically inhibits Dengue protease
J. Song·bioRxiv·Sep 20, 2020
- Using multiscale molecular modeling to analyze possible NS2b-NS3 protease inhibitors from medicinal plants endemic to the Philippines
A. M. F. Cordero, A. A. Gonzales·bioRxiv·May 12, 2023
- A targeted computational screen of the SWEETLEAD database reveals FDA-approved compounds with anti-dengue viral activity
Jasmine Moshiri, David A. Constant, … Karla Kirkegaard·mBioPeer-reviewed·Dec 22, 2020
- Crystallographic fragment screening of the dengue virus polymerase reveals multiple binding sites for the development of non-nucleoside antiflavivirals
Manisha Saini, Jasmin Cara Aschenbrenner, … Eddy Arnold·Journal of Medicinal ChemistryPeer-reviewed·Sep 2, 2025
- Molecular dynamics suggests antiviral compounds active against Dengue Virus show similar binding patterns to Zika Virus proteins
Daniel Ferreira de Lima Neto, Anderson Pereira Soares, … Carlos Francisco Sampaio Bonafé·bioRxiv·May 7, 2018
- Identification of novel thiazole derivatives as flaviviral protease inhibitors against DENV and JEV
Sheikh Murtuja, Sayan Das, … Venkatesan Jayaprakash·Antimicrobial Agents and ChemotherapyPeer-reviewed·Feb 24, 2025